AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 26372470 — intervention group
Group type: COMPARATOR
Intervention: Control (no reminders)
Number of subjects: 4173
Study 24217301 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C (2 g orally)
Number of subjects: 93
Study 24217301 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamins C + E (2 g vitamin C with 600 mg vitamin E orally)
Number of subjects: 93
Study 24217301 — intervention group
Group type: COMPARATOR
Intervention: Control (no medication)
Number of subjects: 93
Study 21923417 — intervention group
Group type: EXPERIMENTAL
Intervention: Simplified urethropexy
Number of subjects: 104
Study 21923417 — intervention group
Group type: COMPARATOR
Intervention: Control group without urethropexy
Number of subjects: 104
Study 18821157 — intervention group
Group type: EXPERIMENTAL
Intervention: Telerehabilitation using the Apraxia Battery for Adults - 2 (ABA-2)
Number of subjects: 11
Study 18821157 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face assessment using the Apraxia Battery for Adults - 2 (ABA-2)
Number of subjects: 11
Study 17368451 — intervention group
Group type: EXPERIMENTAL
Intervention: Balloon catheter
Number of subjects: 229
Study 17368451 — intervention group
Group type: COMPARATOR
Intervention: Cervical vacuum cup
Number of subjects: 229
Study 15168289 — intervention group
Group type: EXPERIMENTAL
Intervention: V.A.C. therapy
Number of subjects: 11
Study 15168289 — intervention group
Group type: COMPARATOR
Intervention: Conventional conservative therapy
Number of subjects: 11
Study 10896709 — intervention group
Group type: EXPERIMENTAL
Intervention: Diffusion tensor imaging (DTI)
Number of subjects: 5
Study 8881671 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted advertising designed to attract high-risk individuals
Number of subjects: 0
Study 8881671 — intervention group
Group type: COMPARATOR
Intervention: Non-targeted advertising requesting individuals who felt at risk of skin cancer
Number of subjects: 0
Study 8881671 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted advertising
Number of subjects: 0
Study 1592346 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin (40 mg/day)
Number of subjects: 8
Study 1592346 — intervention group
Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (600 mg/day)
Number of subjects: 8
Study 1592346 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin (40 mg/day) plus Ursodeoxycholic acid (600 mg/day)
Number of subjects: 8
Study 3922503 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypochlorhydria after transient illness
Number of subjects: 6
Study 2439007 — intervention group
Group type: COMPARATOR
Intervention: 1 microgram intradermal HBV vaccine given to neonates with BCG, followed by two doses of 1.0 microgram intradermal HBV vaccine.
Number of subjects: 32
Study 2439007 — intervention group
Group type: COMPARATOR
Intervention: Two doses of 2 micrograms HBV vaccine intradermally after a 20 micrograms intramuscular dose or three doses of 2 micrograms intradermally.
Number of subjects: 32
Study 2439007 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 micrograms of HBV vaccine given intradermally to 20 young children with a multiple orifice head fired by a jet gun.
Number of subjects: 32
Study 2439007 — intervention group
Group type: COMPARATOR
Intervention: Control group received 20 micrograms HBV intramuscularly followed by two 10 micrograms doses intramuscularly.
Number of subjects: 32
Study 31786135 — intervention group
Group type: EXPERIMENTAL
Intervention: CPCB‐RPE1 implant (3.5×6.25 mm)
Number of subjects: 16
Study 29598986 — intervention group
Group type: EXPERIMENTAL
Intervention: RMT with aromatic oil (RA)
Number of subjects: 44
Study 29598986 — intervention group
Group type: EXPERIMENTAL
Intervention: RMT without aromatic oil (RM)
Number of subjects: 44
Study 29598986 — intervention group
Group type: COMPARATOR
Intervention: Standardised sham massage (SM)
Number of subjects: 44
Study 28162037 — intervention group
Group type: EXPERIMENTAL
Intervention: Couples-level, telephone-based behavioral intervention
Number of subjects: 198
Study 28162037 — intervention group
Group type: COMPARATOR
Intervention: Individual intervention
Number of subjects: 198
Study 26595968 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-channel electrical stimulation and microcurrent therapy
Number of subjects: 0
Study 23230124 — intervention group
Group type: COMPARATOR
Intervention: 0 mg zeranol
Number of subjects: 144
Study 23230124 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 mg zeranol
Number of subjects: 144
Study 23230124 — intervention group
Group type: EXPERIMENTAL
Intervention: 24 mg zeranol
Number of subjects: 144
Study 23230124 — intervention group
Group type: EXPERIMENTAL
Intervention: 36 mg zeranol
Number of subjects: 144
Study 21907949 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual antiplatelet therapy (DAPT) with clopidogrel (300 mg loading dose before TAVI, followed by 75 mg daily for 3 months) plus aspirin (100 mg lifelong)
Number of subjects: 0
Study 21907949 — intervention group
Group type: COMPARATOR
Intervention: Aspirin alone (100 mg lifelong)
Number of subjects: 0
Study 21907949 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual antiplatelet therapy (DAPT) with clopidogrel and aspirin
Number of subjects: 0
Study 18560914 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum neuron-specific enolase levels measured at 2, 24, and 48 hours after traumatic brain injury
Number of subjects: 169
Study 18560914 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum neuron-specific enolase levels in patients who died within 30 days after trauma
Number of subjects: 169
Study 18560914 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuron-specific enolase as a biomarker
Number of subjects: 169
Study 16816766 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 305
Study 16816766 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimal Intervention Strategy (MIS)
Number of subjects: 305
Study 12782826 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral feeding (clear liquid diet on the first postoperative day, then advanced to a regular diet)
Number of subjects: 65
Study 12782826 — intervention group
Group type: COMPARATOR
Intervention: TEP feeding (feeding through tracheoesophageal puncture, nothing orally until the seventh postoperative day)
Number of subjects: 65
Study 12782826 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral feeding
Number of subjects: 65
Study 12782826 — intervention group
Group type: COMPARATOR
Intervention: TEP feeding
Number of subjects: 65
Study 10889118 — intervention group
Group type: EXPERIMENTAL
Intervention: Er:YAG laser vitrectomy
Number of subjects: 30
Study 10889118 — intervention group
Group type: COMPARATOR
Intervention: Mechanical vitrectomy
Number of subjects: 30
Study 8818186 — intervention group
Group type: EXPERIMENTAL
Intervention: L-lactic acid
Number of subjects: 0
Study 8818186 — intervention group
Group type: EXPERIMENTAL
Intervention: D,L-lactic acid
Number of subjects: 0
Study 8818186 — intervention group
Group type: COMPARATOR
Intervention: D-lactic acid
Number of subjects: 0
Study 1429406 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine (20 mg qd)
Number of subjects: 14
Study 1429406 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 3900148 — intervention group
Group type: EXPERIMENTAL
Intervention: Piracetam
Number of subjects: 257
Study 3900148 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 257
Study 31843026 — intervention group
Group type: EXPERIMENTAL
Intervention: Educative article featuring a lay individual with personal experience of suicidality (n = 86)
Number of subjects: 266
Study 31843026 — intervention group
Group type: EXPERIMENTAL
Intervention: Educative article featuring a mental health expert (n = 90)
Number of subjects: 266
Study 31843026 — intervention group
Group type: COMPARATOR
Intervention: Unrelated article (control group, n = 90)
Number of subjects: 266
Study 30124584 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate (TPM)
Number of subjects: 29
Study 30124584 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam (LZP)
Number of subjects: 29
Study 30124584 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 29
Study 27579836 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous bilateral cochlear implantation
Number of subjects: 19
Study 27579836 — intervention group
Group type: COMPARATOR
Intervention: Unilateral cochlear implantation (noise side turned off)
Number of subjects: 19
Study 25489410 — intervention group
Group type: EXPERIMENTAL
Intervention: Dark chocolate snacks plus sugar-free cocoa beverage (DC)
Number of subjects: 60
Study 25489410 — intervention group
Group type: COMPARATOR
Intervention: Non-chocolate snacks plus sugar-free non-cocoa beverage (NC)
Number of subjects: 60
Study 22145605 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoloop ligature
Number of subjects: 90
Study 22145605 — intervention group
Group type: EXPERIMENTAL
Intervention: 45-mm stapler
Number of subjects: 90
Study 22145605 — intervention group
Group type: EXPERIMENTAL
Intervention: One nonabsorbable Hem-o-lok clip
Number of subjects: 90
Study 22145605 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 90
Study 20508468 — intervention group
Group type: EXPERIMENTAL
Intervention: F+AnE
Number of subjects: 20
Study 20508468 — intervention group
Group type: COMPARATOR
Intervention: G+AnE
Number of subjects: 20
Study 20508468 — intervention group
Group type: EXPERIMENTAL
Intervention: F+AE
Number of subjects: 20
Study 20508468 — intervention group
Group type: COMPARATOR
Intervention: G+AE
Number of subjects: 20
Study 18569019 — intervention group
Group type: EXPERIMENTAL
Intervention: Granulocyte-colony stimulating factor (G-CSF) 5 microg/kg, o.d. for 5 days after adjuvant chemotherapy
Number of subjects: 60
Study 18569019 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 16055779 — intervention group
Group type: EXPERIMENTAL
Intervention: Ziprasidone
Number of subjects: 126
Study 16055779 — intervention group
Group type: COMPARATOR
Intervention: Olanzapine
Number of subjects: 126
Study 12434478 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical corticosteroid therapy
Number of subjects: 0
Study 12434478 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic immunosuppression
Number of subjects: 0
Study 10795673 — intervention group
Group type: EXPERIMENTAL
Intervention: Conservative therapy (n = 12)
Number of subjects: 40
Study 10795673 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic suture repair with access channels (n = 10)
Number of subjects: 40
Study 10795673 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic minimal central resection, intrameniscal fibrin clot and suture repair (n = 7)
Number of subjects: 40
Study 10795673 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic partial meniscectomy (n = 11)
Number of subjects: 40
Study 8636745 — intervention group
Group type: EXPERIMENTAL
Intervention: ICRF-187
Number of subjects: 38
Study 8636745 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 38
Study 1561036 — intervention group
Group type: EXPERIMENTAL
Intervention: Verbalization of sensations
Number of subjects: 120
Study 1561036 — intervention group
Group type: COMPARATOR
Intervention: Silence
Number of subjects: 120
Study 1561036 — intervention group
Group type: EXPERIMENTAL
Intervention: Disclosure of sensations
Number of subjects: 120
Study 1561036 — intervention group
Group type: COMPARATOR
Intervention: Disclosure of thoughts
Number of subjects: 120
Study 3885387 — intervention group
Group type: EXPERIMENTAL
Intervention: Noscapine (30 mg)
Number of subjects: 0
Study 3885387 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextromethorphan (20 mg)
Number of subjects: 0
Study 3885387 — intervention group
Group type: EXPERIMENTAL
Intervention: Dihydrocodeine (30 mg)
Number of subjects: 0
Study 3885387 — intervention group
Group type: EXPERIMENTAL
Intervention: Codeine (60 mg)
Number of subjects: 0
Study 3885387 — intervention group
Group type: EXPERIMENTAL
Intervention: Codeine (20 mg)
Number of subjects: 0
Study 3885387 — intervention group
Group type: EXPERIMENTAL
Intervention: Codeine (30 mg)
Number of subjects: 0
Study 3885387 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30609212 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin 100 mg once daily
Number of subjects: 458
Study 30609212 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 458
Study 29438808 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium (18 μg qd)
Number of subjects: 20
Study 29438808 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 27830980 — intervention group
Group type: EXPERIMENTAL
Intervention: MMC-augmented repair (Group B)
Number of subjects: 40
Study 27830980 — intervention group
Group type: COMPARATOR
Intervention: No MMC (Group A)
Number of subjects: 40
Study 25897953 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat diet with 79% energy from fat
Number of subjects: 11
Study 25897953 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat diet with 90% energy from fat
Number of subjects: 11
Study 25897953 — intervention group
Group type: COMPARATOR
Intervention: Mixed diet with 29% energy from fat
Number of subjects: 11
Study 25897953 — intervention group
Group type: EXPERIMENTAL
Intervention: Independent of diet
Number of subjects: 11
Study 24401626 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Focused Ultrasound (HIFU)
Number of subjects: 268
Study 24401626 — intervention group
Group type: COMPARATOR
Intervention: Cortical hormone
Number of subjects: 268
Study 20516435 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative chemotherapy (paclitaxel-carboplatin) followed by surgery
Number of subjects: 624
Study 20516435 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (paclitaxel-carboplatin) after surgery
Number of subjects: 624
Study 20516435 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 624
Study 18086944 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactotripeptides (200 mL dairy drink with 14 mg lactotripeptides)
Number of subjects: 135
Study 18086944 — intervention group
Group type: EXPERIMENTAL
Intervention: Concentrated fermented milk lactotripeptides
Number of subjects: 135
Study 18086944 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzymatic lactotripeptides
Number of subjects: 135
Study 18086944 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic lactotripeptides
Number of subjects: 135
Study 18086944 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 135
Study 16150815 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoke alarm give-away program
Number of subjects: 40
Study 16150815 — intervention group
Group type: COMPARATOR
Intervention: Control group (no smoke alarm give-away)
Number of subjects: 40
Study 14522728 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-glucan-enriched barley (8.1-11.9 g beta-glucan/d)
Number of subjects: 18
Study 14522728 — intervention group
Group type: COMPARATOR
Intervention: Control (isoenergetic dose of 6.5-9.2 g glucose/d)
Number of subjects: 18
Study 10330387 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial rate-adaptive pacing
Number of subjects: 97
Study 10330387 — intervention group
Group type: COMPARATOR
Intervention: No pacing
Number of subjects: 97
Study 7795837 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium supplementation (1 g of calcium carbonate)
Number of subjects: 698
Study 7795837 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium supplementation (360 mg of magnesium diglycine)
Number of subjects: 698
Study 7795837 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 698
Study 2046334 — intervention group
Group type: EXPERIMENTAL
Intervention: Heroin hydrochloride (3.0 mg)
Number of subjects: 6
Study 2046334 — intervention group
Group type: EXPERIMENTAL
Intervention: Heroin hydrochloride (6.0 mg)
Number of subjects: 6
Study 2046334 — intervention group
Group type: EXPERIMENTAL
Intervention: Free morphine
Number of subjects: 6
Study 2046334 — intervention group
Group type: EXPERIMENTAL
Intervention: Total morphine
Number of subjects: 6
Study 2046334 — intervention group
Group type: COMPARATOR
Intervention: Morphine and codeine administration
Number of subjects: 6
Study 7446455 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C, 800 mg four times daily for 2 days before surgery and 2 weeks after surgery
Number of subjects: 175
Study 7446455 — intervention group
Group type: COMPARATOR
Intervention: Lactose placebo
Number of subjects: 175
Study 30821047 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipragliflozin 25 mg/day
Number of subjects: 0
Study 30821047 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipragliflozin 50 mg/day
Number of subjects: 0
Study 30821047 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipragliflozin 100 mg/day
Number of subjects: 0
Study 30821047 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 28235249 — intervention group
Group type: EXPERIMENTAL
Intervention: Secukinumab 150 mg
Number of subjects: 219
Study 28235249 — intervention group
Group type: EXPERIMENTAL
Intervention: Secukinumab 75 mg
Number of subjects: 219
Study 28235249 — intervention group
Group type: EXPERIMENTAL
Intervention: Secukinumab (both doses)
Number of subjects: 219
Study 28235249 — intervention group
Group type: EXPERIMENTAL
Intervention: Secukinumab
Number of subjects: 219
Study 28235249 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 219
Study 25886846 — intervention group
Group type: EXPERIMENTAL
Intervention: Bespoke recruitment procedures involving hospital therapists screening patients and making referrals to the trial team.
Number of subjects: 94
Study 25886846 — intervention group
Group type: EXPERIMENTAL
Intervention: Inclusive recruitment and watchful waiting strategies.
Number of subjects: 94
Study 23478477 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-hour flotation REST session
Number of subjects: 24
Study 23478477 — intervention group
Group type: COMPARATOR
Intervention: 1-hour seated control (passive recovery)
Number of subjects: 24
Study 21317198 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral amoxicillin
Number of subjects: 558
Study 21317198 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular benzathine penicillin G (IM BPG)
Number of subjects: 558
Study 19744615 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary streptokinase (ICSK) 250 kU
Number of subjects: 95
Study 19744615 — intervention group
Group type: COMPARATOR
Intervention: No additional therapy (Control)
Number of subjects: 95
Study 17878421 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequent nocturnal hemodialysis (6 times weekly)
Number of subjects: 52
Study 17878421 — intervention group
Group type: COMPARATOR
Intervention: Conventional hemodialysis (3 times weekly)
Number of subjects: 52
Study 15562842 — intervention group
Group type: EXPERIMENTAL
Intervention: CABG+TMLR
Number of subjects: 44
Study 15562842 — intervention group
Group type: COMPARATOR
Intervention: CABG alone
Number of subjects: 44
Study 11532463 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous transdermal E(2) plus acetate nomegestrolo (group A1)
Number of subjects: 97
Study 11532463 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal E(2) continuously administered (group B1)
Number of subjects: 97
Study 11532463 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term suspension of HRT (group A2)
Number of subjects: 97
Study 11532463 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term suspension of HRT (group B2)
Number of subjects: 97
Study 11532463 — intervention group
Group type: COMPARATOR
Intervention: No medication (group C)
Number of subjects: 97
Study 9754191 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac 0.5% ophthalmic solution
Number of subjects: 120
Study 9754191 — intervention group
Group type: COMPARATOR
Intervention: Diclofenac 0.1% ophthalmic solution
Number of subjects: 120
Study 7653444 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil (12 g/day of fish oil, approximately 8.5 g of n-3 fatty acids)
Number of subjects: 35
Study 7653444 — intervention group
Group type: COMPARATOR
Intervention: Rapeseed oil (12 g/day of rapeseed oil)
Number of subjects: 35
Study 2765430 — intervention group
Group type: EXPERIMENTAL
Intervention: Mefenamic acid (500 mg thrice daily for 3‐5 days in two cycles)
Number of subjects: 40
Study 2765430 — intervention group
Group type: EXPERIMENTAL
Intervention: Danazol (100 mg twice daily for 60 days)
Number of subjects: 40
Study 837964 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASA)
Number of subjects: 0
Study 30851137 — intervention group
Group type: EXPERIMENTAL
Intervention: disposable device
Number of subjects: 18
Study 30851137 — intervention group
Group type: EXPERIMENTAL
Intervention: eGO and mod devices
Number of subjects: 18
Study 30851137 — intervention group
Group type: COMPARATOR
Intervention: all devices
Number of subjects: 18
Study 30851137 — intervention group
Group type: EXPERIMENTAL
Intervention: mod, e-Pipe, and eGO
Number of subjects: 18
Study 30851137 — intervention group
Group type: EXPERIMENTAL
Intervention: perceived speed of urge relief
Number of subjects: 18
Study 26910818 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher plasma tHcy concentrations in women
Number of subjects: 3309
Study 26910818 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher plasma tHcy concentrations in men
Number of subjects: 3309
Study 25746563 — intervention group
Group type: EXPERIMENTAL
Intervention: Sumatriptan/Naproxen Sodium
Number of subjects: 34
Study 25746563 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 25746563 — intervention group
Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 34
Study 24641096 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed dye laser (PDL) treatment followed by twice daily applications of timolol gel
Number of subjects: 22
Study 24641096 — intervention group
Group type: COMPARATOR
Intervention: Pulsed dye laser (PDL) treatment alone
Number of subjects: 22
Study 22928795 — intervention group
Group type: EXPERIMENTAL
Intervention: Home care program (Choices for Healthy Aging [CHA])
Number of subjects: 298
Study 22928795 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 298
Study 19203157 — intervention group
Group type: EXPERIMENTAL
Intervention: ePREP intervention
Number of subjects: 77
Study 19203157 — intervention group
Group type: COMPARATOR
Intervention: Placebo intervention
Number of subjects: 77
Study 17878954 — intervention group
Group type: EXPERIMENTAL
Intervention: Naturopathic care
Number of subjects: 75
Study 17878954 — intervention group
Group type: COMPARATOR
Intervention: Standardized physiotherapy
Number of subjects: 75